323 related articles for article (PubMed ID: 19751400)
1. T lymphocyte responses to heterologous secondary dengue virus infections.
Rothman AL
Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E36-41. PubMed ID: 19751400
[TBL] [Abstract][Full Text] [Related]
2. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever.
Fink J; Gu F; Vasudevan SG
Rev Med Virol; 2006; 16(4):263-75. PubMed ID: 16791836
[TBL] [Abstract][Full Text] [Related]
3. Immunopathological mechanisms in dengue and dengue hemorrhagic fever.
Green S; Rothman A
Curr Opin Infect Dis; 2006 Oct; 19(5):429-36. PubMed ID: 16940865
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactive memory CD8(+) T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner.
Beaumier CM; Mathew A; Bashyam HS; Rothman AL
J Infect Dis; 2008 Feb; 197(4):608-17. PubMed ID: 18275279
[TBL] [Abstract][Full Text] [Related]
5. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.
Vaughn DW; Green S; Kalayanarooj S; Innis BL; Nimmannitya S; Suntayakorn S; Endy TP; Raengsakulrach B; Rothman AL; Ennis FA; Nisalak A
J Infect Dis; 2000 Jan; 181(1):2-9. PubMed ID: 10608744
[TBL] [Abstract][Full Text] [Related]
6. Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren.
Mangada MM; Endy TP; Nisalak A; Chunsuttiwat S; Vaughn DW; Libraty DH; Green S; Ennis FA; Rothman AL
J Infect Dis; 2002 Jun; 185(12):1697-703. PubMed ID: 12085313
[TBL] [Abstract][Full Text] [Related]
7. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand.
Endy TP; Nisalak A; Chunsuttitwat S; Vaughn DW; Green S; Ennis FA; Rothman AL; Libraty DH
J Infect Dis; 2004 Mar; 189(6):990-1000. PubMed ID: 14999601
[TBL] [Abstract][Full Text] [Related]
8. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response.
Guilarde AO; Turchi MD; Siqueira JB; Feres VC; Rocha B; Levi JE; Souza VA; Boas LS; Pannuti CS; Martelli CM
J Infect Dis; 2008 Mar; 197(6):817-24. PubMed ID: 18269315
[TBL] [Abstract][Full Text] [Related]
9. Immunopathogenesis of Dengue hemorrhagic fever.
Rothman AL; Ennis FA
Virology; 1999 Apr; 257(1):1-6. PubMed ID: 10208914
[No Abstract] [Full Text] [Related]
10. Impaired T cell proliferation in acute dengue infection.
Mathew A; Kurane I; Green S; Vaughn DW; Kalayanarooj S; Suntayakorn S; Ennis FA; Rothman AL
J Immunol; 1999 May; 162(9):5609-15. PubMed ID: 10228044
[TBL] [Abstract][Full Text] [Related]
11. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever.
Mongkolsapaya J; Dejnirattisai W; Xu XN; Vasanawathana S; Tangthawornchaikul N; Chairunsri A; Sawasdivorn S; Duangchinda T; Dong T; Rowland-Jones S; Yenchitsomanus PT; McMichael A; Malasit P; Screaton G
Nat Med; 2003 Jul; 9(7):921-7. PubMed ID: 12808447
[TBL] [Abstract][Full Text] [Related]
12. Dengue hemorrhagic fever with special emphasis on immunopathogenesis.
Kurane I
Comp Immunol Microbiol Infect Dis; 2007 Sep; 30(5-6):329-40. PubMed ID: 17645944
[TBL] [Abstract][Full Text] [Related]
13. Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever.
Yeh WT; Chen RF; Wang L; Liu JW; Shaio MF; Yang KD
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):84-90. PubMed ID: 16965355
[TBL] [Abstract][Full Text] [Related]
14. Immunity and immunopathology in dengue virus infections.
Kurane I; Ennis FE
Semin Immunol; 1992 Apr; 4(2):121-7. PubMed ID: 1617166
[TBL] [Abstract][Full Text] [Related]
15. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections.
Libraty DH; Endy TP; Houng HS; Green S; Kalayanarooj S; Suntayakorn S; Chansiriwongs W; Vaughn DW; Nisalak A; Ennis FA; Rothman AL
J Infect Dis; 2002 May; 185(9):1213-21. PubMed ID: 12001037
[TBL] [Abstract][Full Text] [Related]
16. Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?
Loke H; Bethell DB; Phuong CX; Dung M; Schneider J; White NJ; Day NP; Farrar J; Hill AV
J Infect Dis; 2001 Dec; 184(11):1369-73. PubMed ID: 11709777
[TBL] [Abstract][Full Text] [Related]
17. Lower activation-induced T-cell apoptosis is related to the pathological immune response in secondary infection with hetero-serotype dengue virus.
Yang W; Yan H; Ma Y; Yu T; Guo H; Kuang Y; Ren R; Li J
Immunobiology; 2016 Mar; 221(3):432-9. PubMed ID: 26655144
[TBL] [Abstract][Full Text] [Related]
18. Antibodies determine virulence in dengue.
Halstead SB
Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E48-56. PubMed ID: 19751402
[TBL] [Abstract][Full Text] [Related]
19. Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever.
Chen RF; Liu JW; Yeh WT; Wang L; Chang JC; Yu HR; Cheng JT; Yang KD
FEMS Immunol Med Microbiol; 2005 Apr; 44(1):43-50. PubMed ID: 15780577
[TBL] [Abstract][Full Text] [Related]
20. Dengue immune response: low affinity, high febrility.
Welsh RM; Rothman AL
Nat Med; 2003 Jul; 9(7):820-2. PubMed ID: 12835692
[No Abstract] [Full Text] [Related]
[Next] [New Search]
